AblinR. J., BronsonP., SoanesW. A., WitebskyE.: Tissue and species-specific antigens of normal human prostatic tissue. J. Immunol., 104; 1329–1339 (1970).
2.
AndreassiF., BorboniP., D'AlposM., MancaP.: Utilità dell'antigene prostatico specifico nella diagnostica dell'adenocarcinoma della prostata. Urologia, 53; 567–572 (1986).
3.
FlocksR. H., UrichV. C., PatelC. A., OpitzJ. H.: Studies on the antigenic properties of prostatic antigens. J. Urol., 131; 134–143 (1984).
4.
HellerE. J.: Prostatic acid phosphatase: its current clinical status. J. Urol., 137; 1091–1103 (1987).
5.
KuriyamaM., WangM. C., LeeC. L., KillianC. S., PapsideroL. D., InajiH., LoorR. M., LnM. F., NishimaT., SlackN. H., MurphyG. P., ChuT. M.: Multiple evaluation in human prostate cancer with the use of tissue specific antigens. J. Natl. Cancer Inst., 68; 99–105 (1982).
6.
LiedtkeJ. R., BatjerD. J.: Measurement of prostatic specific antigen by radioimmunoassay. Clin. Med., 30; 659–662 (1984).
7.
PapsideroL. D., KuriyamaM., WangM. C., HoroszewicsJ. S., LeongS. S., ValenzuelaL. A., MurphyG. P., ChuT. M.: Prostate antigen: a marker for human prostatic epithelial cells. J. Natl. Cancer Inst., 66; 37–42 (1981).
8.
RomasA. N.: Prostatic acid phosphatase: current concept. Seminar in Urology, 1; 3 (1983).
9.
SmithA. J.Jr.: New methods of endocrine management of prostatic cancer. J. Urol., 137 (1987).
10.
WangM. C., ValenzuelaL. A., MurphyG. P., ChuT. M.: Purification of a human prostate antigen. Invest. Urol., 17; 159–163 (1979).
